Navigation Links
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia

STAMFORD, Conn., Feb. 23 /PRNewswire-FirstCall/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that Australia's Therapeutic Goods Administration, the Australian equivalent of the U.S. FDA, has cleared the Zargis StethAssist™ and Zargis Cardioscan™ devices for sale in Australia.

StethAssist allows healthcare professionals to record and visualize heart, lung and other body sounds and share the findings via the Internet with colleagues. The Cardioscan heart sound analysis software is designed to help physicians analyze cardiac sounds for the identification and classification of suspected heart murmurs, which can be signs of heart disease.  Both devices connect wirelessly to a Bluetooth®-enabled digital stethoscope for the recording and playback of sounds.

Zargis Medical was a co-recipient of Popular Science magazine's 2009 "Innovation of the Year" award for Cardioscan. A Popular Science video regarding Cardioscan may be viewed at

Australia's population of more than 21 million people is served by approximately 48,000 physicians, making the nation an important market for Zargis. In addition, the country's vast physical size, and the fact that 34% of Australia's population resides in rural and remote regions, makes the telemedicine capabilities of StethAssist and Cardioscan a strong fit for the Australian healthcare system. The introduction of these devices into Australia will provide benefits during face-to-face patient encounters and allow healthcare providers to extend the use of auscultation (listening with a stethoscope) through the Internet to situations and environments where face-to-face encounters are not practical.

This clearance allows Zargis to immediately begin marketing StethAssist, Cardioscan and the compatible stethoscope in all Australian states and territories. To order Cardioscan or inquire about distribution opportunities visit

About Zargis Medical Corp.

Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation. Zargis is majority-owned by Speedus Corp. (NASDAQ: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or, or visit the following Web sites: and

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

SOURCE Speedus Corp.

Back to top



SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
2. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
3. Zargis Cardioscan Cleared for Sale in Canada
4. Zargis Cardioscan(TM) Featured on The Early Show on CBS
5. Zargis Cardioscan The Intelligent Stethoscope Now Available on
6. Zargis Cardioscan Jointly Named as Finalist in 2010 Edison Best New Product Awards
7. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
8. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
9. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
10. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
11. Robbins & Myers Announces Regular Quarterly Cash Dividend
Post Your Comments:
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
(Date:11/30/2015)... SINGAPORE , Nov. 30, 2015  QT Vascular ... Vascular", and together with its subsidiaries, TriReme Medical LLC ... global company engaged in the design, assembly and distribution ... of vascular disease, is pleased to announce that a ... Court of Appeals for the Federal Circuit ("Federal ...
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... four states in the U.S. require dental technicians to be certified or obtain ... industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists that ...
(Date:11/30/2015)... MN (PRWEB) , ... November 30, 2015 , ... ... at . The directory is specialized and only includes chiropractic clinics ... to find a competent and trustworthy alternative health practitioner when back pain sets ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... experience this summer, ushering in a new era of publicly accessible automated technology. ... shuttle, will continue to offer guests an up-close look at the shuttle at ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... and fun atmosphere for Halloween festivities, the Word of Life Christian Church of ... board game, and featuring a giant 1.25 ton pile of candy dubbed “Candy ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... community across the United States to access life-saving information provided directly ... Mesothelioma will consist of three individual conferences in three major cities: Houston, ...
Breaking Medicine News(10 mins):